Tony Ho

Tony W.
Ho was the founder of Neuronyx, Inc. since 2000, serving as Chief Scientific Officer from 2000 to 2003.
Current jobs include Independent Director at Hangzhou Qihan Biotech Co., Ltd. since 2022, Independent Director at Engrail Therapeutics, Inc. since 2020, Adjunct Associate Professor at the University of Pennsylvania, Chief Science Officer at Pivotal Bioventure Partners Investment Advisor LLC since 2022, and Chief Science Officer at Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd. Former jobs include Independent Director at iTeos Therapeutics, Inc. from 2021 to 2025, Head-Merck Research Laboratories at Merck & Co., Inc., Assistant Professor at The Johns Hopkins Hospital, Inc., Head-Neurology & Ophthalmology at Merck Research Laboratories Massachusetts LLC, Senior Vice President & Head-Oncology at AstraZeneca AG from 2012 to 2017, Executive Vice President-Research & Development at CRISPR Therapeutics AG from 2017 to 2021, and Assistant Professor-Neurology at The Johns Hopkins University from 1997 to 2000.
Education includes an undergraduate degree from the University of California, Los Angeles and a doctorate from The Johns Hopkins University School of Medicine.